| 13.49 Data as of Jun 18 | -0.01 / -0.07%Today’s Change | 9.06 Today|||52-Week Range 14.92 | +21.42% Year-to-Date |
| Did Derma Sciences Squander Its Latest Sales Increase? Jun 07 / MotleyFool.com |
| Previous close | 13.50 |
| Today’s open | 13.56 |
| Day’s range | 13.36 - 13.56 |
| Volume | 26,069 |
| Average volume (3 months) | 43,245 |
| Market cap | $229.2M |
| Dividend yield | -- |
| Earnings growth (last year) | -97.96% |
| Earnings growth (this year) | -82.99% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +16.00% |
| P/E ratio | NM |
| Price/Sales | 1.91 |
| Price/Book | 2.38 |
| Today’s change | Today’s % change | |
|---|---|---|
| ZLTQZELTIQ Aesthetics In... | +0.14 | +2.26% |
| RTIXRTI Biologics Inc | +0.07 | +1.62% |
| VASCVascular Solutions I... | +0.24 | +1.59% |
| ATECAlphatec Holdings In... | +0.14 | +7.18% |
| Next reporting date | August 13, 2013 |
| EPS forecast (this quarter) | -$0.48 |
| Annual revenue (last year) | $72.6M |
| Annual profit (last year) | -$12.1M |
| Net profit margin | -16.61% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chairman, President & Chief Executive Officer Edward J. Quilty, MBA |
Executive Vice President- Operations Frederic Eigner, MBA |
Corporate headquarters Princeton, New Jersey |
